InnoCare Pharma Limited (OTCMKTS:INCPF) Short Interest Update

InnoCare Pharma Limited (OTCMKTS:INCPF) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 3,707,000 shares, a growth of 11.3% from the November 30th total of 3,330,000 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ? days.

InnoCare Pharma Price Performance

InnoCare Pharma stock opened at $3.26 on Wednesday. InnoCare Pharma has a 12 month low of $3.26 and a 12 month high of $3.72. The company has a fifty day moving average price of $3.26 and a two-hundred day moving average price of $3.26.

About InnoCare Pharma

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder.